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Codon usage limitation in the expression of HIV-1 envelope
glycoprotein
Jürgen Haas*‡, Eun-Chung Park† and Brian Seed*†
Background: The expression of both the env and gag gene products of human
immunodeficiency virus type 1 (HIV-1) is known to be limited by cis elements in
the viral RNA that impede egress from the nucleus and reduce the efficiency of
translation. Identifying these elements has proven difficult, as they appear to be
disseminated throughout the viral genome. 
Results: Here, we report that selective codon usage appears to account for a
substantial fraction of the inefficiency of viral protein synthesis, independent of
any effect on improved nuclear export. The codon usage effect is not specific to
transcripts of HIV-1 origin. Re-engineering the coding sequence of a model
protein (Thy-1) with the most prevalent HIV-1 codons significantly impairs Thy-1
expression, whereas altering the coding sequence of the jellyfish green
fluorescent protein gene to conform to the favored codons of highly expressed
human proteins results in a substantial increase in expression efficiency. 
Conclusions: Codon-usage effects are a major impediment to the efficient
expression of HIV-1 genes. Although mammalian genes do not show as profound
a bias as do Escherichia coli genes, other proteins that are poorly expressed in
mammalian cells can benefit from codon re-engineering.
Background
The mature envelope glycoproteins of human immuno-
deficiency virus type 1 (HIV-1), gp120 and gp41, form a
heterodimeric membrane complex embedded in the lipid
bilayer that circumscribes the viral inner capsid. Expression
of envelope proteins, like those of the gag polyprotein and
reverse transcriptase, is facilitated by a cis-acting element in
the viral mRNA known as the rev-responsive element or
RRE [1–7], and by the action of rev, a small RNA-binding
polypeptide encoded by a subgenomic RNA overlapping
the coding region of the envelope glycoproteins [8,9]. 
Rev has been reported to exert its effect at two or more
stages in the expression of a viral gene product: first by
expediting the export to the cytoplasm of viral RNAs
bearing the RRE [1,4,5,10–16], and subsequently by
improving the translational potency of RRE-containing
transcripts [17–19]. What causes viral mRNAs to be inade-
quately expressed is not clear. Several studies point to the
existence of poorly localized sequences within the gag and
env coding regions that attenuate expression [10,20–24].
One of these inhibitory sequences has been shown to
overlap the RRE itself [25–27], but others have proven
more difficult to localize. For example, the concerted
change of four coding segments, of approximately 30
nucleotides each, within the 5′ end of the gag coding
sequence produced a transcript that was substantially rev-
independent; further dissection of the inhibitory sequences
proved difficult, however, as mutation of all four regions
was required to sustain the increased protein synthesis
[28]. Cellular factors, including heterogenous ribonucleo-
protein C (hnRNP C), or a serologically related protein,
have been found to form complexes with a 270 residue
inhibitory sequence, suggesting that intranuclear retention
may be mediated by sequence-specific interactions [29].
Nonetheless, an explanation for the lower translational
efficiency of the mRNA template remains to be advanced. 
The envelope proteins of HIV-1 are a natural target for
vaccines and for post-infection treatments to limit viral
spread. Despite a great deal of effort aimed at developing
and studying the viral envelope proteins, little is known
about the factors that limit their expression, the role of
non-CD4 cofactors in viral entry, or the mechanisms of
tissue tropism. The poor expression of envelope proteins
limits the titer of retroviral pseudotypes, making it diffi-
cult to develop analytical tools that restrict the success or
failure of infection to membrane-proximal events. In
attempting to address this problem, we considered the
profound bias in the codon usage of the env proteins, a bias
that extends to the gag and pol proteins [30–33]. Figure 1
illustrates the divergence between the codon prevalence
found in the coding region for the envelope protein of the
HIV-1 LAV isolate and that found in a compendium of
highly expressed human genes. Here, we report on the
consequences of codon bias, and on the favorable outcome
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of the systematic replacement of the native codons of
gp120 with codons chosen to reflect more closely the
codon preference of highly expressed human genes. 
The surprising efficacy of codon replacement for gp120 led
us to explore the consequences of codon re-engineering for
the expression of two small test proteins: Thy-1, an abun-
dant cell-surface protein of rodent thymocytes, and green
fluorescent protein (GFP) [34–36], a jellyfish (Aequorea vic-
toria) protein that is relatively poorly expressed in mam-
malian cells. Conversion of the Thy-1 coding sequence to
that of a synthetic gene with the codon preference of HIV-
1 envelope protein gave severely attenuated expression,
whereas replacement of the endogenous codons of GFP
with those of highly expressed mammalian proteins
resulted in a substantial increase in synthetic efficiency.
Results
Construction of a synthetic gp120 gene based on optimal
codon usage
To explore whether codon bias accounted for the poor
expression of envelope glycoproteins we constructed a
synthetic gene encoding the gp120 segment of HIV-1,
based on the sequence of the prototype virus of the most
common North American subtype, HIV-1MN. The syn-
thetic gp120 was assembled from chemically synthesized
long oligonucleotides that were subsequently amplified in
the crude state by polymerase chain reaction (PCR). Some
deviations from strict adherence to optimized codon usage
were made to accommodate the introduction of unique
restriction sites into the resulting gene at approximately
100 base-pair intervals (Fig. 2). In addition, because the
endogenous secretory peptide of envelope is known to
function inefficiently [37], it was replaced by the leader
peptide of the human CD5 antigen, which efficiently
directs the synthesis and export of secreted and mem-
brane-bound proteins [38]. The chimeric gp120 precursor
gene was inserted in a mammalian cDNA expression
vector under the control of the human cytomegalovirus
(CMV) immediate early promoter.
Expression of wild-type and synthetic gp120
To evaluate the relative potency of the wild-type and
synthetic gp120 coding sequences, we compared the out-
comes of transient transfection of the synthetic and native
genes, as well as the result of replacement of the endoge-
nous gp120 secretory leader sequence with that of the
human CD5 antigen. As shown in Figure 3, the synthetic
gene product was expressed at a very high level compared
with that of the wild-type gp120, whether expressed with
the native or CD5 leader, and as assessed either by
immunoprecipitation with a CD4–immunoglobulin fusion
protein or by enzyme-linked immunosorbent assay; in the
latter assay, expression of synthetic gp120 exceeded that
of the native protein with CD5 leader by 41-fold to several
hundred-fold, depending on the experiment. Because
optimal expression of native envelope sequences requires
both the RRE in cis and rev in trans, a similar experiment
was conducted in which both the synthetic and endoge-
nous genes were endowed with the RRE, and expression
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Figure 1
Codon usage of HIV-1 envelope (env) and
highly expressed human (high) genes. The
frequencies (×100) of the individual codons
are shown for each of the degenerately
encoded amino acids, and the most prevalent
codon is shown in bold.Ala Cys Leu SerC
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was measured by immunoprecipitation following cotrans-
fection of the envelope expression plasmids and a plasmid
expressing rev. The results show that rev had no effect on
the expression of the synthetic gene product, but signifi-
cantly enhanced expression of the native gene product
(Fig. 4). Thus, the action of rev is not apparent on a sub-
strate which lacks the coding sequence of the endogenous
viral envelope sequences. Because rev appears to exert its
effect at two steps in the expression of a viral transcript,
we sought to clarify the possible role of export in the
improved expression of the synthetic gene; we therefore
turned to expression from recombinant vaccinia viruses. 
Cytoplasmically transcribed synthetic gp120 is more
efficiently expressed
Native gp120 contains a transcriptional termination
sequence for vaccinia early transcripts, so we used for
comparison a variant virus from which this sequence had
been removed for higher production [39]. As shown in
Figure 5, increased expression of the synthetic gene was
demonstrable when the endogenous gene product and the
synthetic gene product were expressed from vaccinia virus
recombinants under the control of the strong mixed early
and late 7.5 k promoter. Densitometry showed the
improvement to be from 8–50 fold, depending on the cell
type. As vaccinia virus transcripts are created and trans-
lated in the cytoplasm of infected cells, the increased
expression of the synthetic gp120 gene in this circum-
stance cannot be attributed to improved export from the
nucleus. RNA blot analysis showed that the vaccinia tran-
scripts encoding the synthetic gp120 were less abundant
than the transcripts encoding native gp120, indicating that
the increased efficiency of expression was not attributable
to increased mRNA stability (Fig. 6).
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Figure 2
Synthesis of a gp120 (HIV-1MN) gene with
the codon preference of highly expressed
human genes. The shaded portions marked
V1 to V5 indicate segments of the envelope
that show high variability between different
natural isolates, and C1 through C5 denote
regions that remain relatively constant by the
same criteria. Unique restriction sites
engineered into the sequence are shown
above, and a bar diagram of the chemically
synthesized DNA fragments which served as
PCR templates is shown below the sequence.
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Figure 3
Expression of synthetic gp120 in transient
transfection assays. (a) Gel electrophoresis of
immunoprecipitated supernatants of 293T
cells transfected with plasmids expressing
gp120 encoded by the IIIB isolate of HIV-1,
(gp120IIIb), the MN isolate (gp120mn), the
MN isolate modified by substitution of the
endogenous leader peptide with that of the
CD5 antigen (gp120mnCD5L), or the
chemically synthesized gene encoding the MN
variant with the human CD5 leader
(syngp120mn). Supernatants were harvested
following a 12 h labeling period, 40 h post-
transfection, and immunoprecipitated with
CD4–IgG1 fusion protein and protein A
agarose. (b) ELISA of supernatants of
transiently transfected cells. Supernatants of
293T cells transfected by calcium phosphate
with the constructs described above were
harvested after 4 days and tested in a
gp120/CD4 ELISA. 
HIV codon patterns undermine the efficiency of Thy-1
expression 
To explore further the importance of codon usage in
envelope protein expression, we replaced the codons of a
small, typically highly expressed cell-surface protein, the
rat Thy-1 antigen, with the codons most frequently used
by the HIV-1 envelope protein. The resulting sequence
was then edited to remove any message destabilization
motifs of the form AUUUA that had been created, and to
introduce two restriction sites for ease of creation and
manipulation of the resulting sequence. The synthesis
strategy is shown in Figure 7. As shown in Figure 8, the
synthetic rat Thy-1 was expressed approximately 100-fold
less well than the native gene. 
As codon usage for highly expressed proteins can vary
from organism to organism, sequence re-engineering may
prove to be a generally useful way to improve the
expression of genes poorly expressed in mammalian cells.
To explore the generality of this approach we selected a
second small model protein. 
Codon replacement enhances green fluorescent protein
expression
The GFP of the jellyfish Aequorea victoria [34–36] has
attracted attention recently for its possible use as a marker
or reporter for transfection and lineage studies [40], but
has been found to be expressed poorly in mammalian
cells. Examination of a codon usage table constructed from
the native coding sequence showed that the GFP codons
favored either A or U in the third position. The bias in this
case favors A less than does the bias of gp120, but is sub-
stantial. A synthetic gene was created in which the GFP
sequence was recreated in the same manner as for gp120,
and the initiation consensus was replaced with sequences
corresponding to the translational initiation consensus.
The expression of the resulting protein was contrasted
with that of the wild-type sequence, similarly engineered
to bear an optimized translational initiation consensus
(Fig. 9). In addition, the effect of replacing the serine at
position 65 with a threonine (S65T), reported to improve
excitation efficiency at 490 nm and hence preferred for
fluorescence microscopy [41], was examined (Fig. 9).
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Figure 5
Cytoplasmic expression of syngp120mn by vaccinia virus.
Immunoprecipitation of supernatants of human 293 or Hela cells
infected with vaccinia virus expressing wild-type gp120IIIb (vPE-8) or
synthetic gp120mn (syngp120mn). Cells were infected at a multiplicity
of infection of at least 10. Supernatants were harvested after 24 h of
infection and immunoprecipitated with CD4–IgG fusion protein and
protein A agarose. 
Figure 4
Expression of synthetic and wild-type envelope sequences in the
presence of rev in trans and the RRE in cis. 293T cells were transiently
transfected by calcium phosphate coprecipitation of 10 mg plasmid
expressing: the synthetic gp120MN sequence and RRE in cis
(syngp120mnrre), the gp120 portion of HIV-1 IIIB (gp120IIIb), and the
same sequence with the RRE in cis (gp120IIIbrre); each gp120
expression plasmid was cotransfected with 10 mg of either pCMVrev
or CDM7 plasmid DNA. Supernatants were harvested 60 h post-
transfection and immunoprecipitated with CD4–IgG fusion protein and
protein A agarose. The gel exposure time was extended to allow the
induction of gp120IIIBrre by rev to be demonstrated. Shorter
exposures showed no significant dependence of syngp120mnrre
expression upon rev. 
Codon engineering conferred a significant increase in
expression efficiency (and concomitant percentage of cells
apparently positive for transfection), and the combination
of the S65T mutation and codon optimization resulted in a
DNA segment encoding a highly visible mammalian
marker protein (Fig. 9). There was a net improvement in
fluorescence per cell of between 40–120 fold, depending
on detection conditions.
Discussion
Phenomenological rules for codon patterns
Examination of Figure 1 shows that three simple rules
describe the pattern of envelope codon usage: first, pre-
ferred codons maximize the number of adenine residues
in the viral RNA; second, T is preferred over C whenever
the third position degeneracy is a pyrimidine; and third,
the dinucleotide CG is highly under-represented. In all
cases but one, the first rule implies that, if the third posi-
tion can be A, that codon will be most frequently used
[31]. In the special case of serine, three codons equally
contribute one A residue to the mRNA; together these
three comprise 85 % of the codons found in envelope tran-
scripts. A particularly striking example of the combined
effects of first and third rules is found in the codon choice
for arginine, in which the AGA triplet comprises 88 % of
all codons. Finally, the third rule implies that the third
position is much less likely to be G whenever the second
position is C, as in the codons for alanine, proline, serine
and threonine (Fig. 1).
Several studies have pointed to a tendency for HIV
reverse transcriptase to exhibit a high frequency of G to A
transition, a phenomenon called G to A hypermutation
[42–44], and it is known that other lentiviruses undergo
similar hypermutation [45]. Although this helps to account
for the general prevalence of A and T, additional hypothe-
ses are needed to account for the bias of A over T in the
third position, a bias that appears to reflect a more general
excess of purines in the viral RNA strand. One suggestion
is that the nucleotide bias should be restated as high A,
low C, and is driven by two factors: the low intracellular
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Figure 6
Increased mRNA concentration does not
account for the higher output of synthetic
gp120. Cytoplasmic RNA was prepared from
(a) COS cells or (b) 293 cells transfected
with expression plasmids (a) or infected with
recombinant vaccinia viruses (b). RNA was
quantitated by slot blot and the relative
concentrations are shown above images of
the slot blot autoradiogram. Actin
concentrations are shown as a control. In all
cases the mRNA concentration of the
synthetic gene was less than that of the native
gene. CDM7, expression vector only. WR,
wild-type vaccinia. vPE-8, recombinant
vaccinia expressing native gp120IIIb. 
Figure 7
Schematic diagram of a rat Thy-1 gene with HIV-1 envelope codon
usage (rTHY-1env). The darkened boxes in the rTHY-1env construct
denote the leader peptide and the sequences in the precursor that
direct the attachment of a phosphatidylinositol glycan anchor. Unique
restriction sites used for assembly of the construct are shown above. 
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concentration of dCTP relative to TTP; and the higher
error rate of HIV reverse transcriptase on RNA templates
than on DNA, which may promote transversions from
pyrimidine residues in the RNA ([44,46]; S. Wain-
Hobson, personal communication).
Why should inefficient codons be prevalent in HIV-1?
Although it is often thought that viruses occupy an
evolutionary niche which places a premium on rapid repli-
cation, persistent infection of a fraction of susceptible
individuals is a common feature of several viral strains and
may be important for the maintenance of a reservoir of
viral genomes that can be transmitted to new hosts. This
appears to be especially true of HIV-1 and HIV-2. Codon
bias may allow the expression of such viruses to be
suppressed in order to minimize the antigenic profile. An
opposing hypothesis, that the presence of adenine
residues in genomic RNA is generally favored in the retro-
viral life cycle — for example, by facilitating the process of
replication — is not consistent with earlier reports that
Visna virus and HIV-1 share similar codon usage, whereas
human T-cell leukemia virus type 1 (HTLV-1) and HIV-1
do not [30], or that murine leukemia virus and HIV-1 are
similarly discordant [31]. Figure 10 illustrates this point
with a compilation of codon frequencies chosen from
envelope glycoproteins of a variety of other retroviruses —
but excluding the lentiviruses — compared with those
drawn from the envelope sequences of five lentiviruses
that are not closely related to HIV-1: bovine immuno-
deficiency virus, caprine arthritis encephalitis virus,
equine infectious anemia virus, feline immunodeficiency
virus, and Visna virus. The codon usage patterns for the
lentiviruses is strikingly similar to that of HIV-1 — in all
cases the preferred codon for HIV-1 is the same as the
preferred codon for the other lentiviruses. In contrast, the
non-lentiviral envelope codons do not show a similar pre-
dominance of A residues, and are also not as skewed
toward third position C and G residues as are the highly
expressed human genes. In general the non-lentiviral
retroviruses appear to exploit the different codons more
equally, a pattern they share with less highly expressed
human genes (data not shown). In addition to the preva-
lence of codons including A, the lentiviral codons also
show the HIV-1 pattern of strong CpG under-representa-
tion, such that the third position for alanine, proline,
serine and threonine triplets is rarely G. The retroviral
envelope triplets of the comparison group show a similar,
but less pronounced under-representation of CpG. The
most obvious difference between lentiviruses and other
retroviruses with respect to CpG prevalence lies in the
usage of the CGX variant of arginine triplets, which is rel-
atively frequently represented among the retroviral enve-
lope coding sequences, but is almost never present among
lentiviral sequences. The under-representation of CpG-
bearing triplets in lentiviruses could be a consequence of
genetic selection to avoid transcriptional silencing by
methylation of CpG cytosines [47], consistent with the
finding that CpG dinucleotides are also under-represented
among untranslated segments of the HIV-1 genome (data
not shown). 
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Figure 8
Surface expression of rat Thy-1 with HIV-1 envelope codon usage.
Shown are flow cytometry histograms of 293T cells transiently
transfected with either wild-type rat Thy-1 (thick line), rat Thy-1 with
envelope codons (thin line) or vector only (dotted line). 293T cells
were transfected with the different expression plasmids by calcium
phosphate coprecipitation and stained with anti-rat Thy-1 monoclonal
antibody OX7 followed by a polyclonal FITC-conjugated anti-mouse
IgG antibody 3 days after transfection. 
Figure 9
Expression of GFP. (a) COS cells transfected with vector only. (b)
COS cells transfected with a CDM7 expression plasmid encoding
native GFP engineered to include a consensus translational initiation
sequence. (c) COS cells transfected with an expression plasmid
having the same flanking sequences and initiation consensus as in (b),
but bearing a codon-optimized gene sequence. (d) COS cells
transfected with an expression plasmid as in (c), but encoding
GFP(S65T).
Representatives of two unusual types of retrovirus were
not included in the group compared with the lentiviruses
in Figure 10: the spumaretroviruses, exemplified by
bovine syncytial virus and the human and simian
spumaviruses; and Walleye dermal sarcoma virus (WDSV),
which appears to constitute a new genus [48]. Viruses of
these two classes show envelope codon-usage patterns
similar to those of the lentiviruses and, like the
lentiviruses, have large genomes that encode several short
open reading frames in addition to the gag, pol and env
constituents [48]. Intriguingly, the spumaviruses, WDSV,
and at least some of the lentiviruses share the presence of
single-stranded gaps in their unintegrated linear DNA
[48–52]. This small constellation of similar attributes
suggests they may have arisen from a common progenitor.
Why is there codon preference in any form?
Codon bias has been observed in many species [53–56],
and a correlation has been noted between high expression
and the use of a stereotyped pattern of codons [54,57].
Although this correlation is not universal ([58]; see also
discussion in [59]), in several cases it has been found that
expression of exogenous gene products in Escherichia coli
can be enhanced by systematic substitution of the
endogenous codons with triplets over-represented in
highly expressed E. coli genes [59,60]. Although highly
expressed mammalian genes show nonrandom codon-
usage patterns, the degree of over-representation of
favored codons is not as pronounced as for highly
expressed bacterial genes. Nonetheless, the data pre-
sented here clearly suggest that codon usage can play an
important role in determining translational efficiency in a
mammalian cell context.
It has been widely assumed that translational efficiencies
of mammalian gene products are governed by initiation; if
they were not, mRNAs would, in general, be maximally
loaded with ribosomes. This study suggests that poorly
translated mRNAs may indeed be maximally loaded.
However, the finding that inferior codons limit transla-
tional efficiency is not necessarily inconsistent with the
view that translational efficiency is governed by initiation.
First, the limitation imposed by inferior codons need not
be kinetic. Instead, an abundance of less favored codons
could incur a significant cumulative probability of failure
to complete the nascent polypeptide. Recent evidence,
however, suggests that premature termination does not
occur with a high enough efficiency to account for the
observed stimulation (E.C.P. and B.S., unpublished obser-
vations). Another possibility is that the inferior codons
reflect a selection for RNA structures that influence the
rate of initiation — for example, if access to ribosomes is
controlled by cues distributed throughout the RNA. In
such a case, lentiviral codons could predispose the RNA to
accumulate in a pool of poorly initiated RNAs. The
sequestered RNA might be given an improved rate of ini-
tiation by the action of rev or other regulatory proteins. No
stimulation by rev would be seen in the event that the
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Figure 10
Codon usage of lentiviral (lenti) and other
retroviral envelope genes. The frequencies
(×100) of the individual codons are shown for
each of the degenerately encoded amino
acids, and the most prevalent codon is shown
in bold. Ala Cys Leu SerC
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RNA did not bear the unfavored sequences, consistent
with these results. Some precedent for the existence of
discrete pools of mRNA can be found in studies of mater-
nal transcript distribution and use in early embryogenesis
[61,62]. RNA adenine methylation, a candidate RNA
modification that might dictate transcript use, seems
unlikely to participate in translational suppression because
the known methylation consensus [63] is not substantially
over-represented among HIV sequences relative to other
retroviruses (data not shown; there is a profound strand
bias in the frequency of the RNA methylation consensus,
however, which is consistent with the purine excess in the
sense strand).
Conclusions
The creation of a synthetic coding sequence based on
codons over-represented in highly expressed human genes
overcomes a major limitation to the translational efficiency
of HIV-1 envelope glycoprotein. Although codon opti-
mization has been used in the past to improve expression
in E. coli of genes from other organisms, similar studies
have not been conducted in mammalian cells, perhaps
because the codon bias of highly expressed mammalian
genes is not as striking as that of E. coli genes. However,
the results obtained here with three unrelated proteins —
HIV-1 gp120, rat cell-surface antigen Thy-1 and GFP
from Aequorea victoria — suggest that codon optimization
may prove to be a fruitful strategy for improving the
expression in mammalian cells of genes that show limited
translational efficiency in their native form.
Materials and methods
Plasmid constructions
The synthetic gp120 gene was generated from eight 160–200 base
oligonucleotides, produced on a Milligen 8750 synthesizer. After
elution with 30 % ammonium hydroxide, the oligonucleotides were
deblocked at 55 °C for 12 h, precipitated with n-butanol and resus-
pended in H2O. 15–25-mer oligonucleotides complementary to the
ends were used to amplify the long oligonucleotides by PCR. Typically,
PCR was carried out using 35 cycles with 55 °C annealing tempera-
ture and 0.2 min extension time. The products were gel purified, phenol
extracted, and used in a subsequent overlap PCR to generate longer
fragments consisting of two adjacent small fragments. These fragments
were cloned into a CDM7-derived plasmid containing a leader
sequence of the CD5 surface molecule followed by a
Nhe1/Pst1/Mlu1/EcoR1/BamH1 polylinker. The correct sequence was
confirmed by DNA sequencing. The gp120IIIb construct was gener-
ated by PCR using a Sal1/Xho1 HIV-1 HXB2 envelope fragment as
template, followed by an exchange of a Kpn1/Ear1 fragment from a
proviral clone. The wild-type gp120 mn constructs used as controls
were cloned by PCR from HIV-1MN (NIH AIDS Repository) infected
C8166 cells and contained either the native env leader or a CD5
leader sequence. Two clones of each construct were tested to avoid
PCR-induced artefacts. The rat Thy-1 gene with the HIV envelope
codon usage (rTHY-1env) was generated using three 150–170-mer
oligonucleotides. In contrast to the syngp120mn, the PCR products
were directly cloned and assembled in pUC12, and subsequently
cloned into CDM7. 
A GFP coding sequence was assembled in a similar manner from six
fragments of approximately 120 bp each, using a strategy for assembly
that relied on the ability of the restriction enzymes BsaI and BbsI to
cleave outside their recognition sequence. Long oligonucleotides were
synthesized which contained portions of the coding sequence of GFP
embedded in flanking sequences encoding EcoRI and BsaI sites at
one end, and BamHI and BbsI sites at the other end, in the configura-
tion EcoRI–BsaI–GFP–BbsI–BamHI. The restriction site ends gener-
ated by the BsaI and BbsI sites were designed to yield compatible
ends between adjacent GFP fragments, each of which was unique and
non-selfcomplementary. The crude synthetic DNA segments were
amplified by PCR, inserted between EcoRI and BamHI in pUC9, and
sequenced. Subsequently, the intact coding sequence was assembled
in a six fragment ligation, using insert fragments prepared with BsaI and
BbsI. Two of six plasmids resulting from the ligation bore an insert of
correct size, and one contained the desired full length sequence. Muta-
tion of Ser65 to Thr was accomplished by PCR, using a primer that
overlapped a unique BssSI site in the synthetic GFP.
Immunoprecipitation
293T cells were transfected by calcium phosphate using small dishes
of 50–70 % confluent cells and 10 mg plasmid DNA. In cotransfection
experiments with rev, cells were transfected with 10 mg gp120IIIb,
gp120IIIbrre, syngp120mnrre or rTHY-1enveg1rre expression plasmid
DNAs and 10 mg pCMVrev (AIDS Repository) or CDM7 plasmid DNA.
After 48–60 h medium was exchanged and cells were incubated for
additional 12 h in Cys/Met-free medium (Gibco) containing 200 mCi
[35S]Cys+Met (ICN). Supernatants were harvested and spun for
15 min at 3000 rpm to remove debris. After addition of the protease
inhibitors leupeptin, aprotinin and PMSF (Sigma) to 2.5 mg ml–1,
50 mg ml–1 and 100 mg ml–1, respectively, 1 ml of supernatant was
incubated with either 10 ml of packed protein A sepharose (Sigma)
alone (rTHY-1enveg1rre) or with protein A sepharose and 3 mg of a
purified CD4–immunoglobulin fusion protein (kindly provided by
Behring) at 4 °C for 12 h. The protein A beads were washed 5 times
with a buffer containing 100 mM Tris pH 7.5, 150 mM NaCl, 5 mM
CaCl2, 1 % NP-40. After the final wash, 10 ml of loading buffer contain-
ing 10 % glycerol, 4 % SDS, 4 % mercaptoethanol and 0.002 %
bromphenol blue was added, samples were boiled for 3 min and
applied on 7 % (all gp120 constructs) or 10 % (rTHY-1enveg1rre)
SDS polyacrylamide gels. Gels were fixed in 10 % acetic acid and
10 % methanol, incubated with Amplify (Amersham) for 20 min, dried
and exposed for 12 h.
ELISA
The concentration of gp120 in culture supernatants was determined
using CD4-coated ELISA plates and goat anti-gp120 antisera in the
soluble phase. Supernatants of 293T cells transfected by calcium
phosphate were harvested after 4 days, spun at 3000 rpm for 10 min
to remove debris and incubated for 12 h at 4° C on the plates (NEN
Dupont). After 6 washes with PBS, 100 ml goat anti-gp120 antisera
diluted 1:200 (AIDS Repository) were added for 2 h. The plates were
washed again and incubated for 2 h with a peroxidase-conjugated
rabbit anti-goat IgG antiserum 1:1000 (Cappel). Subsequently, the
plates were washed and incubated for 30 min with 100 ml substrate
solution containing 2 mg ml–1 o-phenylendiamine (Sigma) in sodium
citrate buffer. The reaction was finally stopped with 100 ml 4 M sulfuric
acid. Plates were read at 490 nm with a Coulter microplate reader. As
a control, purified recombinant gp120IIIb (Repligen) was used.
Vaccinia virus recombinants
Recombinant vaccinia virus expressing syngp120mn under the control
of the 7.5 promoter was generated by cloning a Hind3/Not1 fragment
containing the synthetic gp120mn gene into pTKG. Vaccinia recombi-
nation, plaque purification and generation of high-titer virus stocks was
done in CV-1 cells essentially as described [64]. vPE-8 expresses
HIV-1 IIIB gp120 under the 7.5 promoter [39]. Hela or 293 cells were
infected at a multiplicity of infection of at least 10. Supernatants of 35S-
labelled cells were harvested 24 h post infection and immunoprecipi-
tated as described above.
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Immunofluorescence
293T cells were transfected by calcium phosphate and analyzed for
surface Thy-1 expression after 3 days. Cells were detached with 1 mM
EDTA in PBS and stained with the monoclonal antibody OX-7 (Accu-
rate) and a FITC-conjugated goat anti-mouse immunoglobulin anti-
serum (Cappel). The analysis was done on a EPICS XL cytofluorometer
(Coulter).
Compilation of codon frequency tables
Codon usage by retroviruses was compiled from the envelope precur-
sor sequences of avian leukosis virus, bovine leukemia virus, feline
leukemia virus, gibbon ape leukemia virus, human T-cell leukemia virus
type I, Mason–Pfizer monkey virus, mouse mammary tumor virus, the
10A1 isolate of murine leukemia virus, the 4070A amphotropic isolate
of MLV, rat leukemia virus, and simian sarcoma virus. The codon fre-
quency tables for the non-HIV, non-SIV lentiviruses were compiled from
the envelope precursor sequences for bovine immunodeficiency virus,
caprine arthritis encephalitis virus, equine infectious anemia virus, feline
immunodeficiency virus, and Visna virus.
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